These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28644036)

  • 1. Examining the Effect of Residual Amikacin on Sputum Culture for Nontuberculous Mycobacteria.
    Eagle G; Brown K; Floto RA
    Am J Respir Crit Care Med; 2018 Jan; 197(2):267-269. PubMed ID: 28644036
    [No Abstract]   [Full Text] [Related]  

  • 2. Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum.
    Tsui SY; Yew WW; Li MS; Chan CY; Cheng AF
    Antimicrob Agents Chemother; 1993 May; 37(5):1001-3. PubMed ID: 8517688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease.
    Olivier KN; Griffith DE; Eagle G; McGinnis JP; Micioni L; Liu K; Daley CL; Winthrop KL; Ruoss S; Addrizzo-Harris DJ; Flume PA; Dorgan D; Salathe M; Brown-Elliott BA; Gupta R; Wallace RJ
    Am J Respir Crit Care Med; 2017 Mar; 195(6):814-823. PubMed ID: 27748623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of aerosolized liposomal amikacin as a novel approach for the treatment of nontuberculous mycobacteria in an experimental model of pulmonary infection.
    Rose SJ; Neville ME; Gupta R; Bermudez LE
    PLoS One; 2014; 9(9):e108703. PubMed ID: 25264757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimycobacterial Susceptibility Testing of Nontuberculous Mycobacteria.
    Brown-Elliott BA; Woods GL
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31315954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium triplex pulmonary disease with acquired macrolide resistance in immunocompetent patients.
    Matsuda S; Suzuki S; Morimoto K; Aono A; Nishio K; Asakura T; Sasaki Y; Namkoong H; Nishimura T; Ogata H; Hasegawa N; Kurashima A; Ishii M; Tatsumi K; Mitarai S; Goto H
    Clin Microbiol Infect; 2018 Jun; 24(6):671-672. PubMed ID: 29309938
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nontuberculous mycobacteria in sputum : Recommendations for diagnosis and treatment].
    Rademacher J
    Internist (Berl); 2017 Nov; 58(11):1163-1170. PubMed ID: 29038903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection.
    Ferro BE; Srivastava S; Deshpande D; Pasipanodya JG; van Soolingen D; Mouton JW; van Ingen J; Gumbo T
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6374-6. PubMed ID: 27458221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium brisbanense lung infection facilitated by steroid induced adrenal insufficiency.
    Gynthersen R; Qvist T; Andersen ÅB; Katzenstein TL
    APMIS; 2019 Feb; 127(2):106-108. PubMed ID: 30585355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Mycobacterial Growth Indicator Tube with Culture on RGM Selective Agar for Detection of Mycobacteria in Sputum Samples from Patients with Cystic Fibrosis.
    Eltringham I; Pickering J; Gough H; Preece CL; Perry JD
    J Clin Microbiol; 2016 Aug; 54(8):2047-50. PubMed ID: 27225412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of a single isolation of pathogenic nontuberculous mycobacteria from sputum specimens.
    Koh WJ; Chang B; Ko Y; Jeong BH; Hong G; Park HY; Jeon K; Lee NY
    Diagn Microbiol Infect Dis; 2013 Feb; 75(2):225-6. PubMed ID: 23140755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series.
    Namkoong H; Morimoto K; Nishimura T; Tanaka H; Sugiura H; Yamada Y; Kurosaki A; Asakura T; Suzuki S; Fujiwara H; Yagi K; Ishii M; Tasaka S; Betsuyaku T; Hoshino Y; Kurashima A; Hasegawa N
    BMC Infect Dis; 2016 Aug; 16():396. PubMed ID: 27506679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Macrolide Therapy Following Short-term Combination Antibiotic Treatment of Mycobacterium massiliense Lung Disease.
    Koh WJ; Jeong BH; Jeon K; Kim SY; Park KU; Park HY; Huh HJ; Ki CS; Lee NY; Lee SH; Kim CK; Daley CL; Shin SJ; Kim H; Kwon OJ
    Chest; 2016 Dec; 150(6):1211-1221. PubMed ID: 27167209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchial wash culture is less valuable in patients suspected to have nontuberculous mycobacteria lung disease for bilateral bronchiectasis with nodules.
    Watanabe K; Shinkai M; Shinoda M; Kaneko T
    Int J Mycobacteriol; 2018; 7(2):178-182. PubMed ID: 29900897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Various Culture Media for Detection of Rapidly Growing Mycobacteria from Patients with Cystic Fibrosis.
    Preece CL; Wichelhaus TA; Perry A; Jones AL; Cummings SP; Perry JD; Hogardt M
    J Clin Microbiol; 2016 Jul; 54(7):1797-1803. PubMed ID: 27098962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of hypertonic saline inhalation as a treatment modality in nontuberculous mycobacterial pulmonary disease.
    Huiberts A; Zweijpfenning SMH; Pennings LJ; Boeree MJ; van Ingen J; Magis-Escurra C; Hoefsloot W
    Eur Respir J; 2019 Jul; 54(1):. PubMed ID: 31000680
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.
    Murray MP; Laurenson IF; Hill AT
    Clin Infect Dis; 2008 Jul; 47(2):222-4. PubMed ID: 18532890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nontuberculous Mycobacterial Infections in Children.
    Bhattacharya J; Mohandas S; Goldman DL
    Pediatr Rev; 2019 Apr; 40(4):179-190. PubMed ID: 30936399
    [No Abstract]   [Full Text] [Related]  

  • 19. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS; Chang SC; Shen EP; Hu FR
    PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Kuijper EJ
    Future Microbiol; 2014; 9(9):1095-110. PubMed ID: 25340838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.